Alisol A Exerts Anti-Proliferative Activity against Human Oral Cancer Cells through Triggering JNK/p38 MAPK-Mediated

Yi-Tzu Chen1,2,3, Shao-Hsuan Kao4,5, Chun-Yi Chuang6,7

  • 1School of Dentistry, Chung Shan Medical University, Taichung, 402, Taiwan.

Oncology Research
|November 3, 2025
PubMed
Abstract

Insights

Alisol A, a natural compound, effectively combats oral cancer by inducing apoptosis through the JNK and p38 signaling pathways. This research highlights Alisol A

Area of Science:

  • Pharmacology and Molecular Biology
  • Natural Product Chemistry
  • Cancer Research

Background:

  • Alisol A, derived from Alismatis Rhizoma, possesses known anticancer and neuroprotective properties.
  • Oral cancer remains a significant global health challenge, necessitating novel therapeutic strategies.
  • Understanding the molecular mechanisms of natural compounds like Alisol A is crucial for drug development.

Purpose of the Study:

  • To investigate the anticancer effects of Alisol A on oral cancer cell lines.
  • To elucidate the underlying molecular mechanisms responsible for Alisol A's cytotoxic activity.
  • To evaluate the therapeutic potential of Alisol A in oral cancer treatment.

Main Methods:

  • Cell viability assessed via MTT assay.
  • Cell cycle analysis conducted using flow cytometry.
  • Apoptosis evaluated through Annexin V/PI staining and caspase activation assays.
  • Signaling pathway analysis employed apoptosis-related protein arrays, immunoblotting, and kinase inhibitors.

Main Results:

  • Alisol A significantly reduced oral cancer cell viability and induced apoptosis.
  • Alisol A modulated apoptosis-related proteins, including HO-1, cIAP1, and XIAP.
  • Activation of caspase-3, -8, -9, and PARP cleavage was observed.
  • Alisol A activated MAPK pathways, specifically JNK and p38, which were critical for apoptosis induction.

Conclusions:

  • Alisol A demonstrates potent anticancer activity against oral cancer cells.
  • Apoptosis induction, mediated by caspase activation and JNK/p38 signaling, underlies Alisol A's efficacy.
  • Alisol A shows promise as a potential therapeutic agent for oral cancer.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.8K